ImMage Biotherapeutics

Founded in May 2015, ImMAGE Biotherapeutics Corp. is a seed-funded biotechnology company developing the first universal Immunotherapy to treat patients with an aggressive form of breast cancer called Triple NegativeBreast Cancer (TNBC).

Website :

Call 2018

The 2018 call for applications for the Young Enterprise Initiative – Start in France is now open for Finnish, Italian, Taiwanese, and U.S. companies. The call will open soon for South African and South Korean companies.

Country Programs



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links